PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.54
ESG score 90-95% of ANVS's 63.81. Bill Ackman would demand clear ESG improvement catalysts.
57.89
Environmental score 1.1-1.2x ANVS's 50.14. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
58.17
Social score 80-90% of ANVS's 66.39. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
56.57
Governance score below 80% of ANVS's 74.91. Jim Chanos would check for potential agency conflicts and oversight failures.